Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1063 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Hope Pharma introduces Nithiodote

Nithiodote is a new antodote that includes two medications that are packaged together, Sodium Nitrite Injection and Sodium Thiosulfate Injection. Sodium nitrite helps to remove cyanide from cells

Zydus Pharma, Zynesher acquire Nesher from K-V Pharma

The acquisition also covers K-V Pharma’s certain packaging, manufacturing and laboratory facilities including certain intellectual property, existing and future product opportunities, as well as equipment specific to the

Idenix Pharma Q2 revenues down

Idenix Pharma’s net loss was $13.91m, or $0.15 loss per diluted share, compared to net loss of $16.26m, or $0.23 loss per diluted share, for the same period

Unigene Q2 revenue dips

Unigene’s net loss was $8.44m, or $0.09 loss per diluted share, compared to net loss of $3.64m, or $0.04 loss per diluted share, for the same period in

Unigene in pact with GSK

As per the terms of the agreement, GSK will pay $2.2m as milestones to Unigene for the development and manufacturing activities. These activities are connected to the active

Array, Genentech ink oncology pact

Under the agreement, the companies will develop Genentech’s compound GDC-0425 (RG7602) and Array’s ARRY-575. The tie up allows Genentech to take care of all clinical development and commercialization

Rexahn Pharma receives European patent

The new patent named, ‘Neurotherapeutic compositions comprising a beta-lactam compound,’ includes compounds including clavulanic acid and moxalactam as a treatment for neurological disorders like, Alzheimer’s disease, anxiety, dementia,